# Dynasty Gene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dynasty-gene

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.dynastygene.com
- Total disclosed funding: $17M
- Latest round: Series A (Jun 5, 2021)
- Investors on record: 4

## About

Based in Shanghai, China and established in 2018, Dynasty Gene is a biotechnology company that focuses on the research and development of synthetic biology. In 2019, the company has established a new production and R&D base in Shanghai. Dr. Mancang Zhang, he company's co-founder and CTO, worked in Agilent, Twist, and ABI.

The company engages in the research and development of high-throughput DNA synthesis technology. Its main products include NGS reagents, probe Panel and automatic sample preparation workstation, etc. Automatic sample preparation workstation can automatically process and test samples.

## Funding rounds

- Series A, Jun 5, 2021, $16M — MSA Capital, Volcanics Venture, Nest.Bio Labs
- Series A, Aug 15, 2019 — Volcanics Venture
- Angel, Nov 1, 2018, $1.7M — Volcanics Venture, Shanghai Huali Biotechnology

## Investors

- Volcanics Venture (https://capitalatlas.ai/funds/volcanics-venture) — Angel, Series A
- Shanghai Huali Biotechnology — Angel
- MSA Capital (https://capitalatlas.ai/funds/msa-capital) — Series A
- Nest.Bio Labs (https://capitalatlas.ai/funds/nest-bio-labs) — Series A